Håvard Ove Skjerven
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Håvard Ove Skjerven has a total of 170 co-authors. Here are the top co-authors by number of shared publications:
- Björn Nordlund
Department of Women’s and Children’s Health, Karolinska Institutet, 171 77 Stockholm, Sweden
10 shared publications Karin C. Lødrup Carlsen
Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway
10 shared publicationsRiyas Vettukattil
Institute of Clinical Medicine, University of Oslo Faculty of Medicine, Oslo, Norway
10 shared publications- Cilla Söderhäll
Department of Women's and Children's Health Karolinska Institutet Stockholm Sweden
8 shared publications Gunilla Hedlin
Department of Women's and Children’s Health, Karolinska Institutet, Stockholm, Sweden
8 shared publicationsAnne Cathrine Staff
Institute of Clinical Medicine, University of Oslo Faculty of Medicine, Oslo, Norway
7 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (10) , e70507
International survey of parental and patient perspectives on emerging adrenaline devices for community‐based management of anaphylaxis: An EAACI task force report
Introduction: Intranasal adrenaline has been approved in multiple countries for anaphylaxis treatment, based primarily on pharmacokinetic/pharmacodynamic comparisons to adrenaline autoinjectors (AAIs). Aim: To assess patient and caregiver perspectives regarding emerging non‐injectable adrenaline routes. Methods: Online survey of adults and caregivers of children with food allergy prescribed AAIs, with international dissemination supported by the European Academy of Allergy and Clinical Immunology (February–April 2025). Results: We analyzed 542 responses from caregivers and 224 from adults with food allergy. Effectiveness of adrenaline nasal spray (ANS) compared to AAI was rated “extremely important” by 78% of caregivers and 71% of adults. 48% of caregivers and 42% of adults were “extremely worried” that ANS may not work as well as AAI, and 50% and 44% (respectively) that it may not work well enough. Compared with AAI, respondents were less worried about ANS being painful or difficult to carry, and about fear/embarrassment around use, but more worried about side effects and knowing how to use it. Most anticipated being more comfortable using ANS than AAI, and over half anticipated earlier use during anaphylaxis. Only 17.2% of caregivers and 23.2% of adults preferred to be prescribed ANS only. There was interest in sublingual adrenaline due to portability and reduced needle‐related burden, but confidence depended on comparable speed/effectiveness and feasibility during reactions. Conclusions: Non‐injectable adrenaline is attractive to caregivers and adults, and may improve willingness to carry and use adrenaline. However, demand for evidence of effectiveness, safety, and real‐world feasibility is high, highlighting important information needs for shared decision‐making. image
- 14 October 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (10) , e70507
Open AccessInternational survey of parental and patient perspectives on emerging adrenaline devices for community‐based management of anaphylaxis: An EAACI task force report
Introduction: Intranasal adrenaline has been approved in multiple countries for anaphylaxis treatment, based primarily on pharmacokinetic/pharmacodynamic comparisons to adrenaline autoinjectors (AAIs). Aim: To assess patient and caregiver perspectives regarding emerging non‐injectable adrenaline routes. Methods: Online survey of adults and caregivers of children with food allergy prescribed AAIs, with international dissemination supported by the European Academy of Allergy and Clinical Immunology (February–April 2025). Results: We analyzed 542 responses from caregivers and 224 from adults with food allergy. Effectiveness of adrenaline nasal spray (ANS) compared to AAI was rated “extremely important” by 78% of caregivers and 71% of adults. 48% of caregivers and 42% of adults were “extremely worried” that ANS may not work as well as AAI, and 50% and 44% (respectively) that it may not work well enough. Compared with AAI, respondents were less worried about ANS being painful or difficult to carry, and about fear/embarrassment around use, but more worried about side effects and knowing how to use it. Most anticipated being more comfortable using ANS than AAI, and over half anticipated earlier use during anaphylaxis. Only 17.2% of caregivers and 23.2% of adults preferred to be prescribed ANS only. There was interest in sublingual adrenaline due to portability and reduced needle‐related burden, but confidence depended on comparable speed/effectiveness and feasibility during reactions. Conclusions: Non‐injectable adrenaline is attractive to caregivers and adults, and may improve willingness to carry and use adrenaline. However, demand for evidence of effectiveness, safety, and real‐world feasibility is high, highlighting important information needs for shared decision‐making. image
- Open Access
- 17 June 2026
- Published by BMJ in BMJ Paediatrics Open
- Vol. 10 (1) , e004761
Oscillometric blood pressure values in infants at 3, 6 and 12 months of age: a cohort study
Objective: To determine reference blood pressure (BP) values in a cohort of healthy infants at 3, 6 and 12 months of age. Design: An antenatally recruited population-based mother–child cohort study. Setting: The multicentre Preventing Atopic Dermatitis and ALLergies in children study, recruiting non-selected pregnant women in Norway and Sweden between 2014 and 2016. Infant oscillometric BP was measured at clinical follow-up visits at 3, 6 and 12 months of age. Patients: In total, 2100 infants had BP readings available during infancy. Main outcome measures: Systolic, diastolic and mean arterial BP at each follow-up visit based on successful BP measurements defined as three readings obtained in a calm state with systolic BP within a 20 mm Hg range. Results: Successful BP measurements were obtained in 1778 infants at 3, 6 and/or 12 months of age. Median systolic/diastolic BP (mean arterial pressure) was 95/56 (69) mm Hg at age 3 months, 96/57 (72) mm Hg at 6 months and 95/57 (71) mm Hg at 12 months. Conclusions: This study establishes reference values for oscillometric BP in healthy infants and shows consistent measurements across 3, 6 and 12 months of age.
- 17 June 2026
- Published by BMJ in BMJ Paediatrics Open
- Vol. 10 (1) , e004761
Open AccessOscillometric blood pressure values in infants at 3, 6 and 12 months of age: a cohort study
Objective: To determine reference blood pressure (BP) values in a cohort of healthy infants at 3, 6 and 12 months of age. Design: An antenatally recruited population-based mother–child cohort study. Setting: The multicentre Preventing Atopic Dermatitis and ALLergies in children study, recruiting non-selected pregnant women in Norway and Sweden between 2014 and 2016. Infant oscillometric BP was measured at clinical follow-up visits at 3, 6 and 12 months of age. Patients: In total, 2100 infants had BP readings available during infancy. Main outcome measures: Systolic, diastolic and mean arterial BP at each follow-up visit based on successful BP measurements defined as three readings obtained in a calm state with systolic BP within a 20 mm Hg range. Results: Successful BP measurements were obtained in 1778 infants at 3, 6 and/or 12 months of age. Median systolic/diastolic BP (mean arterial pressure) was 95/56 (69) mm Hg at age 3 months, 96/57 (72) mm Hg at 6 months and 95/57 (71) mm Hg at 12 months. Conclusions: This study establishes reference values for oscillometric BP in healthy infants and shows consistent measurements across 3, 6 and 12 months of age.
- Open Access
- 28 April 2025
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 145 (6)
Early introduction of small amounts of food prevents food allergies
28.04.2025: Debatt - Retningslinjene for spedbarnsernæring bør, i tillegg til amming, fra 3–4 måneders alder inkludere små mengder av matvarer som inneholder de vanligste allergenene.
- 28 April 2025
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 145 (6)
Open AccessEarly introduction of small amounts of food prevents food allergies
28.04.2025: Debatt - Retningslinjene for spedbarnsernæring bør, i tillegg til amming, fra 3–4 måneders alder inkludere små mengder av matvarer som inneholder de vanligste allergenene.
- Open Access
- 11 April 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (4)
Maternal use of snus as smokeless tobacco in pregnancy and infant lung function
Background: Smoking in pregnancy has detrimental effects on infant respiratory health, while the effects of other nicotine-containing products on infant lung function are unclear. We aimed to explore if smokeless tobacco such as snus used in pregnancy increased the risk of lower lung function in infancy and if the associations differed by sex.Methods: From the Scandinavian population-based Preventing Atopic Dermatitis and ALLergies in Children birth cohort, we included 1163 infants with available tidal flow-volume measurements at 3 months of age and maternal self-reported use of nicotine-containing products in pregnancy. The risk of a ratio of time to peak tidal expiratory flow to total expiratory time in utero, 71 out of 120 by snus exclusively and 49 out of 120 by smoking, with six also exposed to snus. By pregnancy week 6, 85.8% of mothers reported stopping nicotine use. The risk of lower lung function was higher in children exposedin uteroto nicotine-containing products with an odds ratio (OR) of 1.63 (95% confidence interval (CI) 1.02–2.59) with a similar tendency for snus exclusively (OR 1.55, 95% CI 0.88–2.71) and smoking (OR 1.79, 0.84–3.84). Effect estimates were similar after adjusting for covariates. No differences of the effect by sex were observed.Conclusion: Our study suggests thatin uteroexposure to not only cigarettes, but also snus, may negatively affect infant lung function.
- 11 April 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (4)
Open AccessMaternal use of snus as smokeless tobacco in pregnancy and infant lung function
Background: Smoking in pregnancy has detrimental effects on infant respiratory health, while the effects of other nicotine-containing products on infant lung function are unclear. We aimed to explore if smokeless tobacco such as snus used in pregnancy increased the risk of lower lung function in infancy and if the associations differed by sex.Methods: From the Scandinavian population-based Preventing Atopic Dermatitis and ALLergies in Children birth cohort, we included 1163 infants with available tidal flow-volume measurements at 3 months of age and maternal self-reported use of nicotine-containing products in pregnancy. The risk of a ratio of time to peak tidal expiratory flow to total expiratory time in utero, 71 out of 120 by snus exclusively and 49 out of 120 by smoking, with six also exposed to snus. By pregnancy week 6, 85.8% of mothers reported stopping nicotine use. The risk of lower lung function was higher in children exposedin uteroto nicotine-containing products with an odds ratio (OR) of 1.63 (95% confidence interval (CI) 1.02–2.59) with a similar tendency for snus exclusively (OR 1.55, 95% CI 0.88–2.71) and smoking (OR 1.79, 0.84–3.84). Effect estimates were similar after adjusting for covariates. No differences of the effect by sex were observed.Conclusion: Our study suggests thatin uteroexposure to not only cigarettes, but also snus, may negatively affect infant lung function.
- Open Access
Infant lung function and early skin barrier impairment in the development of asthma at age 3 years
Background: Largely unexplored, we investigated if lower lung function, impaired skin barrier function by transepidermal water loss (TEWL), eczema, and filaggrin (FLG) mutations in infancy were associated with asthma in early childhood.Methods: From the factorially designed randomized controlled intervention study PreventADALL, we evaluated 1337/2394 children from all randomization groups with information on asthma at age 3 years, and at age 3 months either lung function, TEWL, eczema, and/or FLG mutations. Lower lung function was defined as the time to peak tidal expiratory flow to expiratory time (tPTEF/tE) 9.50 g/m2/h. Eczema was clinically observed, and DNA genotyped for FLG mutations. Asthma was defined as asthma‐like symptoms (≥3 episodes of bronchial obstruction) between age 2–3 years as well as a history of doctor‐diagnosed asthma and/or asthma medication use. Associations were analyzed in logistic regression models, presented with adjusted ORs (aOR) and 95% confidence intervals (CI).Results: Lower lung function and skin barrier impairment were associated with asthma in general; aOR (95% CI) 5.4 (2.1, 13.7) and 1.6 (1.1, 2.5), while eczema and FLG mutations were associated with asthma in children with atopic dermatitis or allergic sensitization only. Stratifying for sex, the risk of asthma was only increased in boys with lower lung function; aOR (95% CI) 7.7 (2.5, 23.6), and in girls with FLG mutations; aOR (95% CI) 3.5 (1.5, 8.2).Conclusion: Lower lung function and impaired skin barrier function in infancy may increase the risk of asthma at age 3 years.
Open AccessInfant lung function and early skin barrier impairment in the development of asthma at age 3 years
Background: Largely unexplored, we investigated if lower lung function, impaired skin barrier function by transepidermal water loss (TEWL), eczema, and filaggrin (FLG) mutations in infancy were associated with asthma in early childhood.Methods: From the factorially designed randomized controlled intervention study PreventADALL, we evaluated 1337/2394 children from all randomization groups with information on asthma at age 3 years, and at age 3 months either lung function, TEWL, eczema, and/or FLG mutations. Lower lung function was defined as the time to peak tidal expiratory flow to expiratory time (tPTEF/tE) 9.50 g/m2/h. Eczema was clinically observed, and DNA genotyped for FLG mutations. Asthma was defined as asthma‐like symptoms (≥3 episodes of bronchial obstruction) between age 2–3 years as well as a history of doctor‐diagnosed asthma and/or asthma medication use. Associations were analyzed in logistic regression models, presented with adjusted ORs (aOR) and 95% confidence intervals (CI).Results: Lower lung function and skin barrier impairment were associated with asthma in general; aOR (95% CI) 5.4 (2.1, 13.7) and 1.6 (1.1, 2.5), while eczema and FLG mutations were associated with asthma in children with atopic dermatitis or allergic sensitization only. Stratifying for sex, the risk of asthma was only increased in boys with lower lung function; aOR (95% CI) 7.7 (2.5, 23.6), and in girls with FLG mutations; aOR (95% CI) 3.5 (1.5, 8.2).Conclusion: Lower lung function and impaired skin barrier function in infancy may increase the risk of asthma at age 3 years.
- Open Access
- 27 December 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (3) , 652-659.e5
Home-Based Double-Blind, Placebo-Controlled Challenges for Diagnosis of Delayed Gluten/Milk Hypersensitivity in Children
- 27 December 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (3) , 652-659.e5
Open AccessHome-Based Double-Blind, Placebo-Controlled Challenges for Diagnosis of Delayed Gluten/Milk Hypersensitivity in Children
- Open Access
Skin Barrier Function and Infant Tidal Flow-Volume Loops—A Population-Based Observational Study
Background: The relationship between the skin barrier- and lung function in infancy is largely unexplored. We aimed to explore if reduced skin barrier function by high transepidermal water loss (TEWL), or manifestations of eczema or Filaggrin (FLG) mutations, were associated with lower lung function in three-month-old infants. Methods: From the population-based PreventADALL cohort, 899 infants with lung function measurements and information on either TEWL, eczema at three months of age and/or FLG mutations were included. Lower lung function by tidal flow-volume loops was defined as a ratio of time to peak tidal expiratory flow to expiratory time (tPTEF/tE) tPTEF 2/h (>75th percentile) denoted reduced skin barrier function, and DNA was genotyped for FLG mutations (R501X, 2282del4 and R2447X). Results: Neither a high TEWL, nor eczema or FLG mutations, were associated with a lower tPTEF/tE. While a high TEWL was associated with a lower tPTEF; adjusted OR (95% CI) 1.61 (1.08, 2.42), the presence of eczema or FLG mutations were not. Conclusions: Overall, a high TEWL, eczema or FLG mutations were not associated with lower lung function in healthy three-month-old infants. However, an inverse association between high TEWL and tPTEF was observed, indicating a possible link between the skin barrier- and lung function in early infancy.
Open AccessSkin Barrier Function and Infant Tidal Flow-Volume Loops—A Population-Based Observational Study
Background: The relationship between the skin barrier- and lung function in infancy is largely unexplored. We aimed to explore if reduced skin barrier function by high transepidermal water loss (TEWL), or manifestations of eczema or Filaggrin (FLG) mutations, were associated with lower lung function in three-month-old infants. Methods: From the population-based PreventADALL cohort, 899 infants with lung function measurements and information on either TEWL, eczema at three months of age and/or FLG mutations were included. Lower lung function by tidal flow-volume loops was defined as a ratio of time to peak tidal expiratory flow to expiratory time (tPTEF/tE) tPTEF 2/h (>75th percentile) denoted reduced skin barrier function, and DNA was genotyped for FLG mutations (R501X, 2282del4 and R2447X). Results: Neither a high TEWL, nor eczema or FLG mutations, were associated with a lower tPTEF/tE. While a high TEWL was associated with a lower tPTEF; adjusted OR (95% CI) 1.61 (1.08, 2.42), the presence of eczema or FLG mutations were not. Conclusions: Overall, a high TEWL, eczema or FLG mutations were not associated with lower lung function in healthy three-month-old infants. However, an inverse association between high TEWL and tPTEF was observed, indicating a possible link between the skin barrier- and lung function in early infancy.
- Open Access
- 31 October 2022
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 8 (4)
Infant lung function and maternal physical activity in the first half of pregnancy
Background and aim: Physical activity (PA) in pregnancy is important for maternal and possibly offspring health. To study the early origins of lung function we aimed to determine whether PA in the first half of pregnancy is associated with lung function in healthy 3-month-old infants.Methods: From the general population-based Preventing Atopic Dermatitis and Allergies in Children birth cohort recruiting infants antenatally in Norway and Sweden, all 812 infants (48.8% girls) with available tidal flow–volume measures in the awake state at 3 months of age and mid-pregnancy data on PA were included. PA was self-reported by the mothers and, based on intensity, we categorised them as active or inactive during pregnancy. Furthermore, we defined active mothers as fairly or highly active. The main outcome was a ratio of time to peak tidal expiratory flow to expiratory time (tPTEF/tE) in uteronicotine exposure and parental atopy.Results: The mean±sdtPTEF/tEwas 0.391±0.08 and did not differ significantly according to maternal PA level in pregnancy. The 290 infants of inactive mothers had higher odds of havingtPTEF/tEtPTEF/tE.
- 31 October 2022
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 8 (4)
Open AccessInfant lung function and maternal physical activity in the first half of pregnancy
Background and aim: Physical activity (PA) in pregnancy is important for maternal and possibly offspring health. To study the early origins of lung function we aimed to determine whether PA in the first half of pregnancy is associated with lung function in healthy 3-month-old infants.Methods: From the general population-based Preventing Atopic Dermatitis and Allergies in Children birth cohort recruiting infants antenatally in Norway and Sweden, all 812 infants (48.8% girls) with available tidal flow–volume measures in the awake state at 3 months of age and mid-pregnancy data on PA were included. PA was self-reported by the mothers and, based on intensity, we categorised them as active or inactive during pregnancy. Furthermore, we defined active mothers as fairly or highly active. The main outcome was a ratio of time to peak tidal expiratory flow to expiratory time (tPTEF/tE) in uteronicotine exposure and parental atopy.Results: The mean±sdtPTEF/tEwas 0.391±0.08 and did not differ significantly according to maternal PA level in pregnancy. The 290 infants of inactive mothers had higher odds of havingtPTEF/tEtPTEF/tE.
- Open Access
- 24 October 2022
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 8 (4)
Infant lung function: criteria for selecting tidal flow–volume loops
Background: Tidal flow–volume (TFV) loops are commonly recorded in infants during sleep, due to the more regular breathing patterns compared to the awake state. Standardised deselection of loops outside pre-specified ranges are based on periods of regular breathing, while criteria and available software for visual evaluation of TFV loops are lacking. We aimed to determine the reliability of standardised criteria for manual selection of infant TFV loops. Methods: Using a pre-defined set of criteria, three independent raters manually evaluated TFV loops among 57 randomly selected awake healthy 3-month-old infants with available TFV measurements in the Scandinavian Preventing Atopic Dermatitis and ALLergies in children (PreventADALL) study. The TFV loops were sampled using the Eco Medics Exhalyzer D. Criteria for selecting TFV loops included reproducible shape and volume with only one peak in tidal expiratory flow (PTEF), excluding loops with no clear or uneven flow towards PTEF. By intraclass coefficient (ICC), the reliability of agreement between raters was determined for the time to PTEF ( t PTEF ) to expiratory time ( t E ) and other TFV loop parameters. Results: Five infants had unsuccessful tests. Among the remaining 52 infants, the raters selected a median of 25, 26 and 15 loops per test. The ICCs (95% CI) were 0.97 (0.92–0.98) for t PTEF / t E , 0.99 (0.99–1.00) for respiratory rate, 0.98 (0.97–0.99) for tidal volume per kg and 0.98 (0.97–0.99) for expiratory volume, reflecting excellent agreement in all categories. Conclusion: Manual TFV loop selection using standardised criteria provides a reliable alternative for lung function measures in awake infants with interrupted breathing cycles in a real-life setting.
- 24 October 2022
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 8 (4)
Open AccessInfant lung function: criteria for selecting tidal flow–volume loops
Background: Tidal flow–volume (TFV) loops are commonly recorded in infants during sleep, due to the more regular breathing patterns compared to the awake state. Standardised deselection of loops outside pre-specified ranges are based on periods of regular breathing, while criteria and available software for visual evaluation of TFV loops are lacking. We aimed to determine the reliability of standardised criteria for manual selection of infant TFV loops. Methods: Using a pre-defined set of criteria, three independent raters manually evaluated TFV loops among 57 randomly selected awake healthy 3-month-old infants with available TFV measurements in the Scandinavian Preventing Atopic Dermatitis and ALLergies in children (PreventADALL) study. The TFV loops were sampled using the Eco Medics Exhalyzer D. Criteria for selecting TFV loops included reproducible shape and volume with only one peak in tidal expiratory flow (PTEF), excluding loops with no clear or uneven flow towards PTEF. By intraclass coefficient (ICC), the reliability of agreement between raters was determined for the time to PTEF ( t PTEF ) to expiratory time ( t E ) and other TFV loop parameters. Results: Five infants had unsuccessful tests. Among the remaining 52 infants, the raters selected a median of 25, 26 and 15 loops per test. The ICCs (95% CI) were 0.97 (0.92–0.98) for t PTEF / t E , 0.99 (0.99–1.00) for respiratory rate, 0.98 (0.97–0.99) for tidal volume per kg and 0.98 (0.97–0.99) for expiratory volume, reflecting excellent agreement in all categories. Conclusion: Manual TFV loop selection using standardised criteria provides a reliable alternative for lung function measures in awake infants with interrupted breathing cycles in a real-life setting.
- Open Access
- 17 October 2022
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 8 (4)
Infant tidal flow–volume parameters and arousal state
Background: Infant lung function can be assessed with tidal flow–volume (TFV) loops. While TFV loops can be measured in both awake and sleeping infants, the influence of arousal state in early infancy is not established. The aim of the present study was to determine whether TFV loop parameters in healthy infants differed while awake compared to the sleeping state at 3 months of age.Methods: From the population-based Scandinavian Preventing Atopic Dermatitis and ALLergies in children (PreventADALL) birth cohort, 91 infants had reproducible TFV loops measured with Exhalyzer®D in both the awake and sleeping state at 3 months of age. The TFV loops were manually selected according to a standardised procedure. The ratio of time to peak tidal expiratory flow (tPTEF) to expiratory time (tE) and the corresponding volume ratio (VPTEF/VE), as well as tidal volume (VT) and respiratory rate were compared using nonparametric tests.Results: The mean (95% CI)tPTEF/tEwas significantly higher while awake compared to the sleeping state: 0.39 (0.37–0.41)versus0.28 (0.27–0.29); with the correspondingVPTEF/VEof 0.38 (0.36–0.40)versus0.29 (0.28–0.30). TheVTwas similar, while the respiratory rate was higher while awake compared to the sleeping state: 53 (51–56) breaths·min−1versus38 (36–40) breaths·min−1.Conclusion: HighertPTEF/tE,VPTEF/VEand respiratory rate, but similarVTwhile awake compared to the sleeping state suggests that separate normative TFV loop values according to arousal state may be required in early infancy.
- 17 October 2022
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 8 (4)
Open AccessInfant tidal flow–volume parameters and arousal state
Background: Infant lung function can be assessed with tidal flow–volume (TFV) loops. While TFV loops can be measured in both awake and sleeping infants, the influence of arousal state in early infancy is not established. The aim of the present study was to determine whether TFV loop parameters in healthy infants differed while awake compared to the sleeping state at 3 months of age.Methods: From the population-based Scandinavian Preventing Atopic Dermatitis and ALLergies in children (PreventADALL) birth cohort, 91 infants had reproducible TFV loops measured with Exhalyzer®D in both the awake and sleeping state at 3 months of age. The TFV loops were manually selected according to a standardised procedure. The ratio of time to peak tidal expiratory flow (tPTEF) to expiratory time (tE) and the corresponding volume ratio (VPTEF/VE), as well as tidal volume (VT) and respiratory rate were compared using nonparametric tests.Results: The mean (95% CI)tPTEF/tEwas significantly higher while awake compared to the sleeping state: 0.39 (0.37–0.41)versus0.28 (0.27–0.29); with the correspondingVPTEF/VEof 0.38 (0.36–0.40)versus0.29 (0.28–0.30). TheVTwas similar, while the respiratory rate was higher while awake compared to the sleeping state: 53 (51–56) breaths·min−1versus38 (36–40) breaths·min−1.Conclusion: HighertPTEF/tE,VPTEF/VEand respiratory rate, but similarVTwhile awake compared to the sleeping state suggests that separate normative TFV loop values according to arousal state may be required in early infancy.